Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1988
11/08/1988CA1244347A1 Stabilized insulin formulations
11/08/1988CA1244345A1 Assay for interferon epsilon
11/08/1988CA1244344A1 Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor- associated markers
11/07/1988EP0275305A4 Dna sequences coding for modified factor viii:c and modified factor viii:c-like polypeptides and processes for producing these polypeptides in high yields.
11/03/1988WO1988008451A1 HUMAN t-PA(u-PA) SUBSTITUTION-MUTANT PROTEINS, RECOMBINANT DNA CODING THEREFOR, TRANSFECTED HOST CELLS, PREPARATION OF THE MUTANT PROTEINS, AND PHARMACEUTICAL COMPOSITIONS
11/03/1988WO1988008450A1 Gene therapy for metabolite disorders
11/03/1988WO1988008449A1 Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof
11/03/1988WO1988008429A1 Immunotherapeutic methods and compositions
11/03/1988WO1988008307A1 Kidney growth accelerator and process for its preparation
11/03/1988WO1988008306A1 Transkaryotic implantation
11/03/1988WO1988008305A1 Method and apparatus for preparing composite skin replacement
11/03/1988DE3713272A1 Plasminogen activator inhibitor type 2 (PAI-2)
11/02/1988EP0289336A2 Aerosolization of protein therapeutic agent
11/02/1988EP0289314A2 Use of IGF-II in the treatment of bone disorders
11/02/1988EP0289287A2 Amyloid peptides
11/02/1988EP0289229A1 Antiviral combinations
11/02/1988EP0289186A2 Process for increasing the growth rate and enhancing the feed efficiency of meat producing livestock
11/02/1988EP0289053A2 Monoclonal antibodies against lymphoma-associated antigens, hybrid cell line producing these antibodies, and use therefore
11/02/1988EP0289034A2 Transkaryotic implantation
11/02/1988EP0288965A2 Peptides with a phospholipase A2 inhibiting activity
11/02/1988EP0288959A2 Novel glycoprotein, production process thereof and immunosuppressive agent containing same as effective ingredient
11/02/1988EP0288897A2 Enkastines: glycopeptides with an enkephalinase-inhibiting effect, process for their preparation and their pharmaceutical use
11/02/1988EP0288841A2 Method of preparing highly purified alpha-1-proteinase inhibitor
11/02/1988EP0288809A1 Bifunctional proteins
11/02/1988EP0288687A2 Monoclonal antibody, hybridoma, their production and use thereof
11/02/1988EP0288478A1 Use of growth hormone for nitrogen retention under hypocaloric conditions.
11/02/1988CN88102023A Porcine growth hormone analogs
11/01/1988US4782141 With organic or hydrohalogen acids
11/01/1988US4782113 Anticancer
11/01/1988US4782044 Composition containing cordiodilatin or fragments thereof and methods of obtaining cardiodilatin
11/01/1988US4782042 Bactericides
11/01/1988US4782014 Diagnosis and management of inflammatory diseases
11/01/1988CA1244009A1 Lh-rh antagonists
11/01/1988CA1244006A1 Substituted peptide compounds
11/01/1988CA1243972A1 Anti-diabetic compounds
11/01/1988CA1243969A1 Monoclonal antibody to a human carcinoma tumor associated antigen
11/01/1988CA1243957A1 Compositions for cosmetic, health- and body- preserving use
11/01/1988CA1243950A1 Process for producing a high purity antihemophilic factor concentrate
11/01/1988CA1243948A1 Stable, storable insulin product for the treatment of acne vulgaris
10/1988
10/26/1988EP0288435A1 Process for the production of proteins
10/26/1988EP0288307A2 Recombinant production of PDGF A-chain polypeptides
10/26/1988EP0288278A2 Chemical derivatives of GHL-CU
10/26/1988EP0288273A2 Crystalline human proinsulin and process for its production
10/26/1988EP0288243A2 Acetylcholinesterase
10/26/1988EP0288058A2 Analogs of (1,7-di-alanine, des-19-leucine) calcitonine
10/26/1988EP0288057A2 Des-19-leucine, 20-glutamine, 21-threonine, 22-tyrosine-calcitonin
10/26/1988EP0288055A1 Use of ODC inhibitors, dacarbazine, and interferon, in the treatment of malignant melanoma
10/26/1988EP0287997A2 Des-19-leucine, 20-glutamine, 21-threonine-calcitonin
10/26/1988EP0287820A1 Human relaxin analogues
10/25/1988US4780530 Antiviral, antitumor agents
10/25/1988US4780456 Pharmaceutical or dietetic composition having a high antiarteriosclerotic activity
10/25/1988US4780453 3'-azido-3'-deoxythymidine or salt thereof
10/25/1988US4780451 Composition and method for producing superovulation in cattle
10/25/1988US4780450 Physically stable composition and method of use thereof for osseous repair
10/25/1988US4780445 Stable in low sulfur oxide concentrations
10/25/1988US4780416 Bactericides, antitumor agents
10/25/1988US4780413 Tetramethylurea enhancing agent
10/25/1988US4780412 Isolation from epithelial cell cultures
10/25/1988US4780401 Novel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applications
10/25/1988US4780313 Antitumor agents
10/25/1988CA1243604A1 Endothelial cell-growth factor
10/20/1988WO1988008135A1 Human monoclonal antibodies binding determinants of gram negative bacteria
10/20/1988WO1988008035A1 IMPROVED METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS
10/20/1988WO1988008032A1 Receptor from the small rhinovirus receptor group
10/20/1988WO1988008005A1 Stlv-iii-related polypeptides, diagnostic systems and assay methods
10/20/1988WO1988008003A1 Production of purified, biologically active, bacterially produced recombinant human csf-1
10/20/1988WO1988007869A2 ANTI-INTERFERON-gamma-ANTIBODIES AND THEIR THERAPEUTIC APPLICATION
10/20/1988WO1988007868A1 Cytolytic factor
10/20/1988WO1988007867A1 Nootropic
10/20/1988WO1988007863A1 Human somatomedin carrier protein subunits and process for producing them
10/20/1988WO1988007862A1 An antacid composition
10/20/1988WO1988007851A1 Liposome entrapped n-methyl-d-aspartate receptor blockers
10/20/1988WO1988006837A3 STRUCTURE OF IgG PLUS ANTIGEN AND COMPLEMENT, ITS MECHANISMS AND ITS IMPORTANT CONSEQUENCES
10/20/1988WO1988006625A3 Arginine-depleted human tumor necrosis factor
10/20/1988EP0253870A4 METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS.
10/20/1988DE3711724A1 System for acting on, in particular destroying, viruses
10/19/1988EP0287509A1 Diagnosing obesity caused by a genetic abnormality and method of therapeutically treating genetically caused obesity
10/19/1988EP0287493A2 Liver growth factor
10/19/1988EP0287470A1 Use of functional polymer resins as a stationary phase in affinity chromatography in the purification of growth factors, and purification process therefor
10/19/1988EP0287395A1 Human rhinovirus peptides
10/19/1988EP0287076A1 Receptor of the minor rhinovirus receptor group
10/19/1988EP0287075A2 Process for the construction of an animal cell line for the production of human beta-interferon
10/19/1988EP0286929A2 Pyrrolidine derivatives, process for their preparation, agents containing them as well as their use
10/19/1988EP0286928A2 2-Acylpyrrolidine derivatives, process for their preparation, agents containing them as well as their use
10/19/1988EP0286869A1 Process for the preparation of cell wall components from Halobacteria, and their use as medicaments
10/19/1988EP0286813A2 Renin-inhibiting amino acid derivatives
10/19/1988CN88101780A Method for stabilizing proteins
10/19/1988CN88100645A Method for recovering somatotropins from dilute aqueous solutions
10/18/1988US4778879 Highly purified human interleukin 2 and method
10/18/1988US4778795 Carboxyalkyl dipeptides as antiglaucoma agents
10/18/1988US4778790 Perhydrothiazepine and perhydroazepine derivatives and their therapeutic use
10/18/1988US4778787 Solvent extracted mixture promotes healing, vascularization, and perfusion; antiischemic agents
10/18/1988CA1243358A1 Radio paging system capable of transmitting common information and receiver therefor
10/18/1988CA1243311A1 Disaccharide derivatives
10/18/1988CA1243309A1 Products based on polymers or copolymers and process for the preparation thereof
10/18/1988CA1243307A1 Peptides affecting gonadal function
10/18/1988CA1243306A1 Biologically active tripeptide and tetrapeptide alkylamides, processes for the preparation thereof and pharmaceutical compositions containing the same
10/18/1988CA1243305A1 Muramyl peptides and processes for their manufacture
10/18/1988CA1243303A1 Peptides antigonistic to corticotropin releasing factor
10/18/1988CA1243302A1 Urotensin peptides